Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-06 Neff Thomas B Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −6,834 246,042
2019-06-06 Kouchakji Elias SVP, Clinical Dev, Drug Safety Shares withheld for taxes −2,058 $38.31 $79K 96,072
2019-06-06 Cotroneo Pat SVP, Finance and CFO Shares withheld for taxes −3,144 $38.31 $120K 253,978
2019-06-06 Chung Christine SVP, China Operations Shares withheld for taxes −3,480 $38.31 $133K 155,075
2019-06-05 Neff Thomas B Chief Executive Officer Exercise or conversion +6,834 $2.90 $20K 2,480,780
2019-06-05 Neff Thomas B Chief Executive Officer Sale −16,878 $38.43 $649K 2,463,902
2019-06-05 Neff Thomas B Chief Executive Officer Sale −1,522 $38.97 $59K 2,462,380
2019-06-05 Neff Thomas B Chief Executive Officer Sale −1,418 $38.52 $55K 59,836
2019-06-05 Neff Thomas B Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −6,834 252,876
2019-06-05 Tamura Toshinari Director Grant or award +4,700 56,400
2019-06-05 Tamura Toshinari Director Grant or award · Stock Option (Right to Buy) +7,800 7,800

Page 33 of 33 · 651 trades